Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00322608
Status:
COMPLETED
Last Update Posted:
2011-01-10
First Post:
2006-05-04
Brief Title:
Study of the Vascular Disrupting Agent NPI-2358 in Patients With Advanced Solid Tumors or Lymphoma
Sponsor:
Nereus Pharmaceuticals Inc
Organization:
Nereus Pharmaceuticals Inc
Organization Data
Organization:
Nereus Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
NPI-2358-100
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nereus Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Kristine C Federico RNBSN
Old Organization:
Nereus Pharmaceuticals Inc